Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

17.28
+0.33001.95%
Post-market: 17.280.00000.00%19:30 EDT
Volume:772.49K
Turnover:13.36M
Market Cap:1.06B
PE:-10.52
High:17.56
Open:17.08
Low:16.79
Close:16.95
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:42.53M
Volume Ratio:0.97
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.14
PE(LYR):-9.42

Loading ...

Janux’s New Prostate Cancer Combo Trial: What Early Signals Could Mean for JANX

TIPRANKS
·
Sep 18

Janux Doses First Patient in Phase 1 Trial of Janx013 in Metastatic Prostate Cancer

Reuters
·
Sep 14

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of Janx013

THOMSON REUTERS
·
Sep 14

Janux’s JANX014 Prostate Cancer Trial Advances, Keeping Early-Stage Upside in Play

TIPRANKS
·
Sep 04

Brinker, Whirlpool, Q32 Bio, Pulte, Janux Trending With Analysts

TIPRANKS
·
Aug 29

Janux Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
Aug 24

Janus Living Prices Share Offering

MT Newswires Live
·
Aug 11

RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Janux Therapeutics Inc (JANX) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Aug 10

Analyst Maintains Buy on Janux Therapeutics, Keeps $60 Price Target Unchanged on Strong Balance Sheet and Clinical Differentiation

TIPRANKS
·
Aug 08

Janux Therapeutics is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 08

Janux Therapeutics price target lowered to $55 from $58 at Guggenheim

TIPRANKS
·
Aug 07

Janux Therapeutics Inc (JANX) Receives a Sell from Barclays

TIPRANKS
·
Aug 07

Analysts’ Top Healthcare Picks: Lyell Immunopharma (LYEL), Janux Therapeutics Inc (JANX)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 EPS $(0.35) Beats $(0.38) Estimate, Sales $10.267M Miss $16.493M Estimate

Benzinga Earnings
·
Aug 07

Janux Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Janux Therapeutics reports Q2 EPS (35c), consensus (29c)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 Basic EPS USD -0.35

THOMSON REUTERS
·
Aug 07

Janux Therapeutics Coverage Assumed by Truist Securities at Buy

Dow Jones
·
Jun 25

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Jun 25